Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy

'develop':31 'diseas':13 'disord':15 'edit':2,23,26,39 'field':18,34 'gene':1,22,25,38 'genet':12 'medic':4 'name':3,27 'pharmaceut':28 'research':7,29 'scientif':6 'therapi':24,40 'treatment':10 'vivo':21,37

Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy

'agent':25 'biopharmaceut':24 'cardiovascular':20,30,56 'cell':1 'clinic':5 'deliveri':50 'diseas':21,31,57 'edit':14,39,65 'field':9,34,60 'gene':13,38,41,45,64 'medic':3 'modul':48 'name':44 'pharmaceut':22,51 'product':43 'regul':47 'therapi':15,40,42,66 'transfer':46 'treatment':18,28,54 'use':6 'vivo':12,37,63

CTX321

Owner

Goods & Services